Bharat Biotech said the evaluation of Covaxin has resulted in several unique product characteristics including long term persistence of immune responses to multiple viral proteins, as opposed to only the spike protein, and has demonstrated broad spectrum neutralizing capability with heterologous SARS-CoV2 strains, thus potentially reducing or eliminating escape mutants.from Moneycontrol Business News https://www.moneycontrol.com/news/business/coronavirus-vaccine-india-|-covaxin-offers-protection-against-mutant-covid-19-strains-says-bharat-biotech-icmr_14632441.html
No comments:
Post a Comment